Doctor profile · Federal record
Dr. Michael Lattanzi
Hematology & Oncology Physician (CMS: Medical Oncology) · Medical Oncology Physician · Student in an Organized Health Care Education/Training Program · Austin, TX
- NPI 1902255276
- Accepts Medicare
- 10 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 3 locations .
- Primary practice
-
6204 Balcones Dr
Austin, TX 787314214
(512) 427-9400
fax (512) 342-2723 - Additional location
-
550 1St Ave
New York, NY 100166402
(212) 263-5506 - Additional location
-
20 Medical Park Dr Ste B
Asheville, NC 288032493
(828) 254-8232
fax (828) 253-4470 - Mailing address
-
Po Box 911230
Dallas, TX 753911230
Credentials & registration
- NPI registered
- June 2016 — 10 yrs on file
- Profile last updated
- September 13, 2022
- Year of graduation
- 2016 — 10 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (2)
- Texas #T5155 · North Carolina #2022-01073
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1902255276. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
98,260
Distinct HCPCS
10
Medicare allowed
$1,375,728
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 18,180 | 16 | $3 | |
J9271 |
Injection, pembrolizumab, 1 mg | 17,200 | 33 | $54 | |
J9267 |
Injection, paclitaxel, 1 mg | 14,103 | 26 | $0 | |
J1453 |
Injection, fosaprepitant, 1 mg | 13,650 | 44 | $0 | |
Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 10,150 | 87 | $0 | |
J1756 |
Injection, iron sucrose, 1 mg | 9,600 | 28 | $0 | |
J0185 |
Injection, aprepitant, 1 mg | 2,730 | 13 | $2 | |
J0897 |
Injection, denosumab, 1 mg | 1,980 | 14 | $23 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,759 | 83 | $0 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 1,280 | 65 | $1 |
In context: peer comparison
Among 8 peers in Austin Hematology & Oncology Physician, average services per provider: 1,180. This provider delivers 83× the peer median.Open Payments
Industry payments received
All-time total
$88,629
Transactions
111
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, INC. | 31 | $24,394.66 | |
| Pfizer INC. | 17 | $16,608.99 | |
| Merck Sharp & Dohme LLC | 15 | $14,552.61 | |
| Exelixis INC. | 24 | $13,731.97 | |
| Astellas Pharma US INC | 10 | $10,216.21 | |
| Aveo Pharmaceuticals, INC. | 5 | $6,481.59 | |
| Astellas Pharma Global Development | 3 | $1,679.71 | |
| Janssen Scientific Affairs, LLC | 2 | $823.90 | |
| Bayer Healthcare Pharmaceuticals INC. | 1 | $91.64 | |
| Celgene Corporation | 2 | $31.45 | |
| AstraZeneca Pharmaceuticals Lp | 1 | $16.67 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
264
Patients
83
Total drug cost
$70,149
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Eliquis (Apixaban) | Brand | 31 | 0 | $19,815 |
| Prednisone | Generic | 27 | 13 | $184 |
| Prochlorperazine Maleate | Generic | 26 | 15 | $397 |
| Dexamethasone | Generic | 25 | 13 | $158 |
| Oxycodone Hcl | Generic | 24 | 18 | $222 |
| Ondansetron Odt (Ondansetron) | Brand | 23 | 13 | $291 |
| Xarelto (Rivaroxaban) | Brand | 20 | 0 | $16,715 |
| Olanzapine | Generic | 17 | 11 | $68 |
| Abiraterone Acetate | Generic | 15 | 0 | $31,474 |
| Lorazepam | Generic | 15 | 0 | $112 |
Frequently asked questions
What is Dr. Michael Lattanzi's medical specialty?
Dr. Michael Lattanzi practices Hematology & Oncology Physician in Austin, TX.
Where does Dr. Michael Lattanzi practice?
Dr. Michael Lattanzi practices at 6204 Balcones Dr, Austin, TX 787314214. Office phone: 5124279400.
What is Dr. Michael Lattanzi's NPI?
Dr. Michael Lattanzi's National Provider Identifier (NPI) is 1902255276, issued by NPPES.
Does Dr. Michael Lattanzi accept Medicare assignment?
Yes. Dr. Michael Lattanzi accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Michael Lattanzi commonly perform?
Top Medicare-reported procedures in 2023: Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881); Injection, pembrolizumab, 1 mg (HCPCS J9271); Injection, paclitaxel, 1 mg (HCPCS J9267). Source: CMS Medicare Physician & Other Practitioners file.